Fact CheckerSign in

NCT07558473Not yet recruiting

Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors

Source: ClinicalTrials.gov · Last updated 3 Nov 2026

Brief summary (registry, in English)

The goal of this study is to learn if an online computerized training program improves processing speed, attention, and working memory in children with a primary brain tumor during and after active cancer treatment. The main questions it aims to answer are: 1. Is the cognitive intervention feasible to administer to children with brain tumors during and after cancer treatment?, 2. Is the cognitive intervention acceptable to children and caregivers?, and 3. Does the cognitive intervention improve neuropsychological functioning? There is no comparison group for this study. Participants will: 1. Complete an online computerized cognitive training program for approximately 15 minutes per day, 5 days a week, for 8 weeks; 2. Have weekly check-ins with the cognitive coach, 3. Complete a survey at the end of the cognitive training program, and 4. Complete pre- and post- neuropsychological testing.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
19 Mar 2026
Start date
30 Dec 2026
Primary completion date
30 Jul 2031
Lead sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
NCT number
NCT07558473

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 30 Dec 2026 to the primary completion date, 30 Jul 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Significant visual, hearing, motor, or cognitive impairment that precludes participation in computerized cognitive training program;

Other

  • Acute medical status (e.g., significant risk for mortality within 3-months of diagnosis).

Who the study is looking for

  • Diagnosis of a primary brain tumor,
  • Children and young adults 5 to 25 years of age at the time of enrollment,
  • Within five years of initial brain tumor diagnosis,
  • Receiving care through the Johns Hopkins neuro-oncology program.

Age in the registry: 5 years to 25 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kennedy Krieger Institute
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.